If you would like to submit a blog post for consideration, please email email@example.com
Groundbreaking Immunotherapy Drug Beats Skin Cancer
A ‘groundbreaking’ immunotherapy drug is helping patients overcome advanced non-melanoma skin cancer.
Cemiplimab is being used at Sir Charles Gaidner Hospital in Perth as part of an international trial. Oncologist Annette Lim, who runs the trial, says most patients have responded with encouraging results.
There were strict criteria for patients to enter the trial, but early results suggest the drug could be a game-changer for non-melanoma skin cancer sufferers.
Dr Lim says the results have been “miraculous” and that some patients respond to cemiplimab very quickly. Patients with large lesions in multiple places have seen their tumours shrink in consecutive scans.
The drug has improved prognoses for some patients with squamous cell carcinoma whose tumours did not respond to surgery, radiotherapy or chemotherapy.
Cancer Council Western Australia says many people disregard non-melanoma skin cancers as trivial and easily treated, and that new developments in immunotherapy are vital for providing terminally ill skin cancer patients with treatment options they may not otherwise have.
O’Leary, C. (November 6, 2017.) ‘Miracle’ drug cemiplimab helps WA grandfather Kim Doherty fight back from ‘terminal’ skin cancer. The West Australian.
Interested in skin cancer medicine?
The HealthCert Professional Diploma programs offer foundation to advanced training in skin cancer medicine, skin cancer surgery or dermoscopy and provide an essential step towards subspecialisation. All programs are university quality-assured, CPD-accredited and count towards multiple Master degree pathways and clinical attachment programs in Australia and overseas. The programs are delivered online and/or face-to-face across most major cities of Australia.